Status:
UNKNOWN
Effect of Highly Bioavailable Curcumin on Subjective Tinnitus
Lead Sponsor:
Henry Ford Health System
Conditions:
Tinnitus, Subjective
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
This study will assess the effectiveness of highly bioavailable curcumin in suppressing subjective tinnitus based on pre- and post-treatment evaluations using the validated Tinnitus Functional Index (...
Detailed Description
Subjects with severe, subjective tinnitus due to sensorineural hearing loss will complete both TFI and THI surveys prior to starting therapy. Subjects will then be randomized to a treatment or placebo...
Eligibility Criteria
Inclusion
- Adults with subjective tinnitus due to sensorineural hearing loss as determined by routine audiogram.
Exclusion
- Adults with subjective tinnitus due to another cause
- Sensitivity or allergy to test compounds
- Use of other off-label medications, substances, treatments specifically for tinnitus mitigation (e.g., anti-depressant/anxiety medications, GABA-inhibitors, psychiatric-based interventions/counseling)
- Pregnancy
- Patients taking anticoagulants to minimize risk of drug-drug interactions.
Key Trial Info
Start Date :
January 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04800107
Start Date
January 6 2021
End Date
December 31 2025
Last Update
April 20 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Michigan Ear Institute
Farmington Hills, Michigan, United States, 48334
2
Michigan Ear Institute
Novi, Michigan, United States, 48374
3
Michigan Ear Institute
Royal Oak, Michigan, United States, 48073